B4GALT2
Basic information
Region (hg38): 1:43978943-43991170
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the B4GALT2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 26 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 27 | 0 | 0 |
Variants in B4GALT2
This is a list of pathogenic ClinVar variants found in the B4GALT2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-43981111-C-G | not specified | Uncertain significance (Jan 09, 2024) | ||
1-43981141-G-T | not specified | Uncertain significance (Apr 27, 2022) | ||
1-43981204-C-T | not specified | Uncertain significance (May 14, 2024) | ||
1-43981209-C-A | not specified | Uncertain significance (Sep 26, 2023) | ||
1-43981242-G-A | not specified | Uncertain significance (May 03, 2023) | ||
1-43981260-G-A | not specified | Uncertain significance (Jul 05, 2023) | ||
1-43981290-C-T | not specified | Uncertain significance (Apr 13, 2023) | ||
1-43981291-G-A | not specified | Uncertain significance (Jun 28, 2022) | ||
1-43981303-G-A | not specified | Uncertain significance (Sep 21, 2023) | ||
1-43981351-G-A | not specified | Uncertain significance (Nov 08, 2022) | ||
1-43981365-C-T | not specified | Uncertain significance (Mar 31, 2022) | ||
1-43981366-G-A | not specified | Uncertain significance (Dec 20, 2023) | ||
1-43981371-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
1-43981384-C-T | not specified | Uncertain significance (Oct 13, 2021) | ||
1-43981392-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
1-43981422-G-T | not specified | Uncertain significance (Jun 24, 2022) | ||
1-43981446-C-T | not specified | Uncertain significance (Mar 17, 2023) | ||
1-43981689-T-C | not specified | Uncertain significance (Oct 02, 2023) | ||
1-43981794-C-T | not specified | Uncertain significance (Jul 29, 2022) | ||
1-43981877-A-G | not specified | Uncertain significance (Apr 07, 2022) | ||
1-43981886-C-T | not specified | Uncertain significance (Jan 02, 2024) | ||
1-43981898-C-T | not specified | Uncertain significance (Feb 22, 2024) | ||
1-43985000-C-T | not specified | Uncertain significance (Aug 13, 2021) | ||
1-43985001-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
1-43985351-C-T | not specified | Uncertain significance (Apr 13, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
B4GALT2 | protein_coding | protein_coding | ENST00000309519 | 7 | 12226 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.198 | 0.800 | 125739 | 0 | 5 | 125744 | 0.0000199 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.88 | 194 | 283 | 0.685 | 0.0000198 | 2583 |
Missense in Polyphen | 69 | 119.58 | 0.57704 | 1045 | ||
Synonymous | -0.317 | 125 | 121 | 1.04 | 0.00000885 | 848 |
Loss of Function | 2.70 | 4 | 15.5 | 0.259 | 8.28e-7 | 171 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000615 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000980 | 0.0000980 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. Can produce lactose.;
- Pathway
- N-Glycan biosynthesis - Homo sapiens (human);Other types of O-glycan biosynthesis - Homo sapiens (human);Mannose type O-glycan biosynthesis - Homo sapiens (human);Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human);Galactose metabolism - Homo sapiens (human);Glycosaminoglycan biosynthesis - keratan sulfate - Homo sapiens (human);Metabolism of carbohydrates;Keratan sulfate biosynthesis;Keratan sulfate/keratin metabolism;Glycosaminoglycan metabolism;Post-translational protein modification;N-Glycan antennae elongation;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;Metabolism;terminal <i>O</i>-glycans residues modification;Galactose metabolism;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;N-Glycan biosynthesis;Galactose metabolism
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.259
- rvis_EVS
- -0.36
- rvis_percentile_EVS
- 29.16
Haploinsufficiency Scores
- pHI
- 0.0636
- hipred
- Y
- hipred_score
- 0.728
- ghis
- 0.506
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.941
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- B4galt2
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- carbohydrate metabolic process;protein glycosylation;memory;locomotory behavior;visual learning;keratan sulfate biosynthetic process;cerebellar Purkinje cell layer development
- Cellular component
- Golgi membrane;nucleoplasm;Golgi apparatus;integral component of membrane;Golgi cisterna membrane;intracellular membrane-bounded organelle
- Molecular function
- beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity;N-acetyllactosamine synthase activity;lactose synthase activity;galactosyltransferase activity;metal ion binding